Sleep Apnea Symptoms in Women: Why It's Often Missed
Sleep apnea has a diagnosis problem in women, and it isn't because women get the condition less often. It's because the diagnostic criteria, the screening questionnaires, and the classic symptom checklist were built almost entirely on data from male patients. The result: women are diagnosed later, after more severe symptoms, and often after years of being told their fatigue is anxiety, depression, or "just stress."
As a licensed Registered Respiratory Therapist with ICU and critical care experience, I want to walk through exactly how sleep apnea shows up differently in women, why it gets missed, and what to do if you suspect you have it.
The Diagnostic Gap: Why Women Are Underdiagnosed
Sleep apnea research historically enrolled predominantly male subjects, and the classic clinical picture — loud snoring, witnessed apneas, obesity, large neck circumference — reflects that population. Screening tools widely used in primary care, including the STOP-BANG questionnaire, were validated primarily in male-dominant cohorts and tend to under-flag women who have real, clinically significant OSA but don't fit the classic profile.
The consequence is measurable: studies estimate that the male-to-female diagnosis ratio for OSA in clinical settings is roughly 3:1 to 9:1, while population-based studies using objective testing rather than clinical referral suggest the true prevalence ratio is closer to 2:1 or even more equal in certain age groups, particularly postmenopausal women. The gap between diagnosed cases and actual prevalence represents a large population of women with untreated sleep apnea.
How Sleep Apnea Symptoms Differ in Women
Women with OSA often present with a symptom cluster that looks different from the male-pattern presentation, and as a result gets attributed to other causes.
Fatigue and Insomnia Rather Than Sleepiness
Men with OSA classically report falling asleep involuntarily during the day — in meetings, while driving, while reading. Women more often report persistent fatigue, a sense of being chronically tired without the same degree of involuntary sleep onset. Some women with significant OSA report insomnia and difficulty staying asleep rather than excessive daytime sleepiness, a presentation that can lead clinicians toward a primary insomnia diagnosis rather than sleep apnea workup.
Mood Symptoms
Depression, anxiety, and irritability are reported more frequently by women with OSA than men with OSA. This is a critical diagnostic trap: a woman presenting with fatigue, low mood, and difficulty concentrating is statistically more likely to be evaluated and treated for depression than referred for a sleep study, even when the underlying driver is untreated sleep apnea. Treating the mood symptoms without addressing the sleep apnea produces incomplete or absent improvement, and the cycle of misattribution continues.
Headaches
Morning headaches, related to overnight hypercapnia and disrupted sleep architecture, are reported more commonly in women with OSA. These are frequently worked up as migraine or tension headache without consideration of an underlying sleep-disordered breathing cause.
Less Prominent or Absent Snoring
Snoring volume and frequency tend to be lower in women with OSA compared to men with equivalent disease severity, partly due to anatomical and hormonal differences in upper airway structure. A woman without loud, classic snoring is less likely to be referred for sleep apnea evaluation by herself, her partner, or her physician — even with a clinically significant AHI.
Restless Legs and Sleep Fragmentation
Women with OSA more frequently report restless sleep, frequent awakenings, and symptoms overlapping with restless legs syndrome, which can further obscure the underlying sleep apnea diagnosis amid a more complex sleep complaint picture.
The Hormonal Dimension: Why Menopause Changes Everything
This is one of the most clinically important and least publicly understood aspects of sleep apnea in women.
Premenopausal Protection
Progesterone has a respiratory stimulant effect, increasing upper airway dilator muscle activity and respiratory drive. Estrogen also influences upper airway muscle tone and fat distribution patterns. Premenopausal women, with higher circulating levels of both hormones, have some degree of relative protection against OSA compared to men of the same age and BMI. This is part of why OSA prevalence is markedly lower in premenopausal women than in age-matched men.
The Menopausal Transition
As estrogen and progesterone decline through perimenopause and menopause, this protective effect diminishes substantially. OSA prevalence in postmenopausal women rises sharply, approaching rates seen in men of similar age within several years of menopause onset. This is not a coincidence of aging alone — it reflects the loss of hormonally-mediated airway protection that existed during the reproductive years.
Hormone replacement therapy has been studied for its effect on OSA in postmenopausal women, with some evidence suggesting modest improvement in respiratory parameters, though it is not currently established or recommended as a primary treatment for OSA. The clinical takeaway is awareness: any woman going through perimenopause or menopause who develops new fatigue, mood changes, morning headaches, or sleep disruption should consider OSA as a differential, particularly if these symptoms emerged or worsened around the menopausal transition.
Pregnancy
Pregnancy introduces its own sleep apnea risk factors: weight gain, fluid retention and nasal congestion (pregnancy rhinitis), elevated progesterone (which can partially offset risk but doesn't eliminate it, particularly with weight gain), and in later trimesters, reduced functional residual lung capacity from the gravid uterus. OSA during pregnancy is associated with gestational hypertension, preeclampsia, gestational diabetes, and adverse fetal outcomes including growth restriction. Snoring that develops or worsens during pregnancy, particularly in the third trimester, warrants evaluation — not dismissal as a normal pregnancy symptom.
Cardiovascular and Metabolic Risk: Is It Different in Women?
The cardiovascular consequences of untreated OSA — hypertension, atrial fibrillation, coronary artery disease, stroke — apply to women as they do to men, and some research suggests women may experience disproportionate cardiovascular risk at a given AHI compared to men, though this area continues to be actively studied. What's clear clinically: women are not protected from the cardiovascular consequences of OSA simply because they're statistically less likely to be diagnosed. The risk exists whether or not the diagnosis has been made. For the complete cardiovascular picture, see our guide on sleep apnea and heart disease.
Polycystic Ovary Syndrome (PCOS) and OSA
Women with PCOS have a substantially elevated risk of OSA independent of BMI, driven by the hormonal and metabolic profile of the condition — elevated androgens, insulin resistance, and associated weight gain patterns. Studies suggest OSA prevalence in women with PCOS may be several times higher than in age- and BMI-matched women without PCOS. Any woman with PCOS who reports fatigue, unrefreshing sleep, or mood symptoms should be screened for OSA as part of her broader metabolic and reproductive health evaluation, not solely focused on the gynecologic and metabolic dimensions of the syndrome.
Getting an Accurate Diagnosis
If you suspect you have sleep apnea and you're a woman without the "classic" male-pattern presentation, here's how to advocate effectively for proper evaluation:
- Describe your actual symptoms specifically — fatigue, morning headaches, mood changes, restless sleep — rather than waiting to be asked about snoring and witnessed apneas specifically
- Mention any hormonal context — perimenopause, menopause, PCOS, pregnancy — as this changes your risk profile significantly and is clinically relevant information your physician needs
- Ask directly about a sleep study if your fatigue or mood symptoms haven't responded to standard treatment for the diagnosis you were initially given (depression treatment without improvement, for example)
- Request an objective test rather than accepting a screening questionnaire score alone as a final determination — STOP-BANG and similar tools have documented lower sensitivity in women
For the full breakdown of home sleep testing versus in-lab polysomnography and which is appropriate for your situation, see our guide on home sleep test vs in-lab sleep study.
Treatment Considerations for Women
CPAP therapy is equally effective for women and men once OSA is diagnosed — there is no different treatment algorithm based on sex. However, a few practical considerations are worth noting:
- Mask fit: Standard mask sizing is often based on average male facial dimensions. Women, on average, have smaller facial structures, and many mask manufacturers now offer dedicated "for her" mask lines designed around smaller, narrower facial profiles for improved seal and comfort.
- Compliance and mood improvement: Given that women with OSA frequently present with mood symptoms, tracking mood alongside standard CPAP compliance metrics (AHI, usage hours) can provide additional motivation and clinical insight during the treatment adjustment period.
- Hair and headgear: A practical, frequently overlooked issue — standard CPAP headgear can be uncomfortable with longer hair or certain hairstyles. Headgear designed to sit higher on the head, away from a ponytail or bun, is available and worth requesting if standard headgear is consistently uncomfortable.
For guidance on getting your CPAP setup configured correctly from day one, see our ResMed AirSense 10 setup guide, and for mask fit troubleshooting, our CPAP mask leak guide.
Frequently Asked Questions
Can thin women have sleep apnea?
Yes. While obesity is the most prominent risk factor for OSA, anatomical factors — retrognathia (recessed jaw), narrow palate, enlarged tonsils, or specific craniofacial structure — can cause clinically significant OSA in women of normal weight. Non-obese OSA is increasingly recognized as a distinct phenotype, and clinicians should not rule out OSA based on body habitus alone, particularly in women presenting with the fatigue, mood, and headache symptom cluster described above.
Does menopause cause sleep apnea?
Menopause itself doesn't directly cause OSA, but the hormonal changes of menopause remove a significant protective factor against the development of OSA, leading to a sharp rise in prevalence in the postmenopausal population. Weight gain commonly associated with the menopausal transition compounds this risk further. The combination of hormonal change and metabolic shift makes the years around menopause a particularly important window for OSA screening.
I was diagnosed with depression but antidepressants haven't helped much. Could it be sleep apnea?
This is a legitimate and common clinical scenario. Persistent fatigue, low mood, and concentration difficulty that don't respond adequately to depression treatment warrant consideration of underlying sleep apnea, particularly in women given the documented overlap between OSA symptom presentation and mood disorder symptoms. This isn't a suggestion to discontinue prescribed depression treatment independently, but rather a reason to raise the possibility of a sleep study with your prescribing physician.
Is sleep apnea during pregnancy dangerous?
Yes, it can be. OSA during pregnancy is associated with gestational hypertension, preeclampsia, gestational diabetes, and adverse outcomes for the fetus including growth restriction. New or worsening snoring during pregnancy, particularly with witnessed pauses in breathing or excessive daytime sleepiness beyond what's typical for pregnancy fatigue, should be discussed with your obstetric provider. CPAP therapy is safe during pregnancy when indicated and is the standard treatment approach.
Will losing weight cure my sleep apnea?
Weight loss can significantly reduce OSA severity and in some cases resolve it, particularly when excess weight is a primary contributing factor. However, for women whose OSA is driven predominantly by hormonal changes (menopause), PCOS, or anatomical factors independent of weight, weight loss alone may provide partial benefit without full resolution. Treatment decisions should be individualized based on your specific contributing factors rather than assuming weight loss is the sole or complete solution.
The Bottom Line
Sleep apnea in women is real, common, and frequently missed — not because it's a different disease, but because the symptom presentation diverges from the classic profile that screening tools and clinical suspicion were built around. Fatigue, mood changes, morning headaches, and insomnia deserve consideration as potential sleep apnea symptoms, particularly in women approaching or past menopause, women with PCOS, and women whose standard treatment for a presumed alternative diagnosis hasn't produced the expected improvement.
If this symptom pattern sounds familiar, advocate for a sleep study. The diagnostic gap exists at the system level — closing it for yourself starts with naming your actual symptoms clearly and asking directly for objective testing.
For the complete foundational picture of sleep apnea diagnosis and treatment, read our guide on sleep apnea symptoms, causes, and treatment. Browse our CPAP machines and mask options, including mask styles designed for smaller facial profiles. Our $49.99 RT Consultation is available if you want clinical guidance on your sleep study results or therapy setup from a licensed Respiratory Therapist.
Written by Yashil Bhatt, RRT — Licensed Registered Respiratory Therapist with ICU and critical care experience and owner of My Respiratory Company.